BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33669477)

  • 1. The Diagnosis of Cystic Fibrosis in Adult Age. Data from the Italian Registry.
    Padoan R; Quattrucci S; Amato A; Carnovale V; Salvatore D; Salvatore M; Campagna G
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33669477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2024; 48(2 Suppl 2):1-41. PubMed ID: 38742380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2022; 46(4 Suppl 2):1-38. PubMed ID: 36102313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2021; 45(3 Suppl 1):1-37. PubMed ID: 34132083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Italian Cystic Fibrosis Registry. Report 2011-2014].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2018; 42(1S1):1-32. PubMed ID: 29506377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Italian Cystic Fibrosis Register - Report 2010].
    Amato A; Ferrigno L; Salvatore M; Toccaceli V;
    Epidemiol Prev; 2016; 40(2 Suppl 2):1-47. PubMed ID: 27291389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012.
    Jackson AD; Jackson AL; Fletcher G; Doyle G; Harrington M; Zhou S; Cullinane F; Gallagher C; McKone E
    Pharmacoeconomics; 2017 Oct; 35(10):1087-1101. PubMed ID: 28699086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with cystic fibrosis having a residual function mutation: Data from the Italian registry.
    Salvatore D; Padoan R; Buzzetti R; Amato A; Giordani B; Ferrari G; Majo F
    Pediatr Pulmonol; 2019 Feb; 54(2):150-157. PubMed ID: 30561903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR.
    Rowe SM; McColley SA; Rietschel E; Li X; Bell SC; Konstan MW; Marigowda G; Waltz D; Boyle MP;
    Ann Am Thorac Soc; 2017 Feb; 14(2):213-219. PubMed ID: 27898234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal outcomes in women with cystic fibrosis: Data from the Italian Cystic Fibrosis Registry.
    Padoan RF; Quattrucci S; Amato A; Salvatore M; Salvatore D; Campagna G
    Acta Obstet Gynecol Scand; 2021 Aug; 100(8):1439-1444. PubMed ID: 34028004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of radiographic and clinical characteristics of low-risk and high-risk cystic fibrosis genotypes.
    Ferril GR; Nick JA; Getz AE; Barham HP; Saavedra MT; Taylor-Cousar JL; Nichols DP; Curran-Everett D; Kingdom TT; Ramakrishnan VR
    Int Forum Allergy Rhinol; 2014 Nov; 4(11):915-20. PubMed ID: 25224556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
    Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
    Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
    Southern KW; Patel S; Sinha IP; Nevitt SJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial.
    Ratjen F; Hug C; Marigowda G; Tian S; Huang X; Stanojevic S; Milla CE; Robinson PD; Waltz D; Davies JC;
    Lancet Respir Med; 2017 Jul; 5(7):557-567. PubMed ID: 28606620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical expression of cystic fibrosis in a large cohort of Italian siblings.
    Terlizzi V; Lucarelli M; Salvatore D; Angioni A; Bisogno A; Braggion C; Buzzetti R; Carnovale V; Casciaro R; Castaldo G; Cirilli N; Collura M; Colombo C; Di Lullo AM; Elce A; Lucidi V; Madarena E; Padoan R; Quattrucci S; Raia V; Seia M; Termini L; Zarrilli F
    BMC Pulm Med; 2018 Dec; 18(1):196. PubMed ID: 30577776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
    Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.